US Patent Issued to Mind-NRG Sarl on March 18 for "Method of effecting neuroprotection using soluble neuregulin isoforms" (German Inventor)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,423, issued on March 18, was assigned to Mind-NRG Sarl (Geneva).

"Method of effecting neuroprotection using soluble neuregulin isoforms" was invented by Andre Schrattenholz (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to soluble Neuregulin-1 isoforms representing Posttranslational Neuregulin-1 modifications as medication in cognition-related neurological disorders, in particular schizophrenia, Alzheimer's and Parkinson's diseases."

The patent was filed on Sept. 4, 2020, under Application No. 17/012,159.

*For further information, including images, charts and tables, please visit: http://patft.uspto.go...